Drug Shortage Report for VINORELBINE INJECTION, USP

Last updated on 2018-08-09 History
Report ID 35007
Drug Identification Number 02431130
Brand name VINORELBINE INJECTION, USP
Common or Proper name 10 mg/ml Vinorelbine (as vinorelbine tartrate)
Company Name GENERIC MEDICAL PARTNERS INC
Market Status MARKETED
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5ml in clear glass vial
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-06
Estimated end date
Actual end date 2018-08-01
Shortage status Resolved
Updated date 2018-08-09
Company comments New batches of 5 ml and 1 ml have been manufactured. Contracted 5 ml demand is now being supplied on allocation. Stock levels are being increased with the manufacture of further batches of both vial sizes.
Health Canada comments
Tier 3 Status No
Contact Address 1500 DON MILLS ROAD, SUITE 711
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-01-24 French Compare
v9 2018-01-24 English Compare
v8 2018-01-10 French Compare
v7 2018-01-10 English Compare
v6 2018-01-05 French Compare
v5 2018-01-05 English Compare
v4 2018-01-05 French Compare
v3 2018-01-05 English Compare
v2 2018-01-05 English Compare
v1 2018-01-05 English Compare

Showing 21 to 30 of 30